Skip to main content

Table 3 Motivations for participation in an HIV vaccine trial by sex

From: Motivations to participate in a Phase I/II HIV vaccine trial: A descriptive study from Dar es Salaam, Tanzania

Categorical statements Men n(%) Women n(%) Total n(%)
Volunteerism to rescue lives of others [altruism] 64 (34.8) 32 (55.2) 96 (39.7)**
Desire to become a role model, to be among the enthusiasts 32 (17.4) 13 (22.4) 45 (18.6)
Researchers’ explanations about HIV/AIDS vaccine studies 36 (19.6) 1 (1.7) 37(15.3)***
To get more knowledge about HIV prevention/vaccine 27 (14.7) 10 (17.2) 37 (15.3)
To know my health status [know health status] 29 (15.8) 7 (12.1) 36 (14.9)
To get knowledge for educating others about HIV or vaccine 29 (15.8) 5 (8.6) 34 (14.0)
To cooperate with researchers in developing an HIV vaccine 21 (11.4) 2 (3.4) 23 (9.5)*
To accomplish personal motivation 14 (7.6) 5 (8.6) 19 (7.9)
To get protection against HIV infection 13 (7.1) 4 (6.9) 17 (7.0)
Magnitude of the disease [AIDS] 14 (7.6) 3 (5.2) 17 (7.0)
Severity of the disease in families – experienced death of a relative due to AIDS 13 (7.1) 2 (3.4) 15 (6.2)
Others (free treatment/insurance, test the strength of vaccine in the body) 6 (3.3) 1 (1.7) 7 (2.9)
  1. Significance denoted by: *** = P < 0.001; ** = P < 0.01; * = P < 0.05
  2. NB: The columns represent multiple responses, and thus cannot add up to 100 %. The same applies to the total number of respondents in each column